The Neuropeptidergic Modulation of Phenomenological Depth: A Review of Oxytocin’s Role in Facilitating States of Pure Consciousness
Preprints.org March 17, 2026 preprint DOI: 10.20944/preprints202603.1209.v1 via OpenAlex
Summary
AI-generated from the abstractOxytocin, a hormone involved in social bonding, may help create the brain conditions for non-dual awareness—a state of consciousness without intentional content. The review proposes that oxytocin down-regulates the amygdala and modulates the Default Mode Network, reducing self-referential processing and supporting ego-dissolution. This neuro-chemical substrate could explain how contemplative traditions achieve pure consciousness. The authors discuss ethical concerns about using neuro-pharmacology to influence meditative states and suggest future clinical applications for psychiatric disorders involving rigid self-narratives.
Study at a glance
| Characteristics | Review |
|---|---|
| Population | Theoretical |
| Topics | Addiction Default mode network |
| Keywords | Consciousness Contemplation Salience neuroscience Perspective graphical |
| Key finding | Oxytocin acts as a critical neuro-modulator of the ego-construct by facilitating amygdala down-regulation and Default Mode Network modulation, creating a neuro-chemical substrate for non-dual awareness. |
Abstract
The nature of consciousness, specifically the state of "pure consciousness"—often characterized in contemplative traditions as a state of awareness devoid of intentional content—has transitioned from a topic of purely philosophical inquiry to a rigorous subject of neuroscientific study. This review synthesizes current clinical and neurobiological research to propose that oxytocin (OT), a nonapeptide traditionally associated with social bonding and parturition, acts as a critical neuro-modulator of the ego-construct. By facilitating the down-regulation of the amygdala and modulating the Default Mode Network (DMN), oxytocin creates the necessary neuro-chemical substrate for non-dual awareness. We explore the neurobiology of the oxytocinergic system, the intersection of social salience and ego-dissolution, and the empirical evidence for OT-mediated shifts in self-referential processing. Finally, we discuss the ethical implications of using neuro-pharmacology to influence meditative states and propose future clinical pathways for treating psychiatric disorders characterized by rigid, pathological self-narratives.